"We have neurology, palliative care and oncology teams located within The University of Kansas Clinical Research Center in Fairway, Kansas. Clinical care and research is carried out in a collaborative environment, leading to breakthroughs in oncology care, Alzheimer's care and more."

During the past decade, The University of Kansas Cancer Center, Investigational Drug Services conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The University of Kansas Cancer Center, Investigational Drug Services" are "Brain Neoplasms" (1 trials), "Brain Neoplasms, Primary" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Castration Resistant Prostate Cancer (CRPC)" (1 trials) and "Follicular Lymphoma (FL)" (1 trials). Many other conditions were trialed in "The University of Kansas Cancer Center, Investigational Drug Services" in a lesser frequency.

Most popular intervention types in "The University of Kansas Cancer Center, Investigational Drug Services" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib" (1 trials), "Elranatamab + Nirogacestat" (1 trials), "Elranatamab + lenalidomide + dexamethasone" (1 trials), "Midazolam" (1 trials) and "PF-06821497" (1 trials). Other intervention names were less common.

The vast majority of trials in "The University of Kansas Cancer Center, Investigational Drug Services" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The University of Kansas Cancer Center, Investigational Drug Services". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The University of Kansas Cancer Center, Investigational Drug Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The University of Kansas Cancer Center, Investigational Drug Services, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".